<?xml version="1.0" ?>
<document id="29802988">
  <sentence id="29802988.s0" text="Recent studies in RAS wild-type (WT) metastatic colorectal cancer (mCRC) suggest that the survival benefits of therapy using anti-epidermal growth factor receptor (anti-positive regulation of protein phosphorylation) and anti-vascular endothelial growth factor (anti-VEGF) antibodies combined with chemotherapy are maximized when the anti-EGFR antibody is given as first-line, followed by subsequent anti-VEGF antibody therapy.">
    <entity charOffset="59-65" id="29802988.s0.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="169-215" id="29802988.s0.e1" ontology_id="GO_0001934" text="positive regulation of protein phosphorylation" type="GO"/>
    <pair e1="29802988.s0.e0" e2="29802988.s0.e1" id="29802988.s0.p0" relation="true"/>
  </sentence>
</document>
